Neonc Technologies Holdings, Inc. develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous syst…
$4.91+1.24%
报价 2026-11-13
市值
$141.7M
EV
$120M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -54.3%
$2.53$10.75
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Biotechnology| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| NTHINeonc Technologies Holdings, Inc. | $141.7M | +1.2% | – | 0% | – | – | – | |
| FATEFate Therapeutics, Inc. | $149.2M | -4.5% | -10.6% | -343% | – | – | – | |
| KRSAKorsana Biosciences, Inc. | $148.2M | +1.2% | – | 61.6% | – | – | – | |
| ARMPArmata Pharmaceuticals, Inc. | $143.9M | +4.0% | +13.3% | 68.2% | – | – | – | |
| ALXOALX Oncology Holdings Inc. | $143.8M | -3.7% | +666.7% | 0% | – | – | – | |
| MGNXMacroGenics, Inc. | $140.6M | -3.9% | -21.0% | 50.4% | – | – | – | |
| CMPXCompass Therapeutics, Inc. | $139.4M | -5.6% | -125.5% | 0% | – | – | – | |
| ABEOAbeona Therapeutics Inc. | $138.3M | +5.7% | +1241.7% | 26.3% | 3.3x | – | – | |
| CNTNTharimmune, Inc. | $136.3M | -5.0% | -100.0% | 100% | – | – | – | |
| 同行中位数 | – | – | -10.6% | 38.4% | 3.3x | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。
研究材料
Filing 摘要
电话会纪要摘要
暂无纪要摘要。